BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo S, Kim JY, Lim Y, Han S, Choi J. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus–related hepatocellular carcinoma after surgical resection. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Diao YK, Kong QY, Yang T. HBsAg Seroclearance and Reduction in Late Recurrence of HBV-related HCC: Causality or Co-existence? J Hepatol 2022:S0168-8278(22)00371-3. [PMID: 35732214 DOI: 10.1016/j.jhep.2022.06.009] [Reference Citation Analysis]
2 Jin B, Du S, Yang H. HBsAg seroclearance reduces the risk of late recurrence in HBV-related HCC. J Hepatol 2022:S0168-8278(22)02929-4. [PMID: 35810929 DOI: 10.1016/j.jhep.2022.06.030] [Reference Citation Analysis]
3 Liu SY, Yuan C, Tong XM. Antiviral therapy, HBsAg seroclearance and late recurrence of Hepatitis B-related hepatocellular carcinoma. J Hepatol 2022:S0168-8278(22)02938-5. [PMID: 35863489 DOI: 10.1016/j.jhep.2022.07.005] [Reference Citation Analysis]